High throughput device isolates and classifies metabolically active CTCs

Researchers from the University of Technology Sydney have developed a new device that can detect and analyze cancer cells from blood samples, enabling doctors to avoid invasive biopsy surgeries, and to monitor treatment progress.

Related Keywords

Sydney ,New South Wales ,Australia ,Australians ,Majid Warkiani ,Otto Warburg ,Emily Henderson ,Cancer Research ,Cancer Research Industry ,University Of Technology Sydney ,School Of Biomedical Engineering ,Technology Sydney ,Biomedical Engineering ,Static Droplet Microfluidic ,Research Industry Focus ,Cancer ,Technology ,Biopsy ,Flood ,Kidney ,Liver ,Metastasis ,Microfluidics ,Research ,Surgery ,